AIMBE
Gene Lay, DVM
AIMBE College of Fellows Class of 2025 For outstanding accomplishments in applying immunology to biology, engineering and medicine, while inspiring contributions to professional societies and educational institutions.
Gene Lay Inducted into the 2025 Class of the AIMBE College of Fellows
Via AIMBE | March 31, 2025WASHINGTON, D.C. – The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Gene Lay, DVM, President and CEO at BioLegend to its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”
Dr. Lay was nominated, reviewed, and elected by peers and members of the College of Fellows “for outstanding accomplishments in applying immunology to biology, engineering and medicine, while inspiring contributions to professional societies and educational institutions…. Continue reading.
...
